trimethoprim has been researched along with norfloxacin in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (51.69) | 18.7374 |
| 1990's | 5 (5.62) | 18.2507 |
| 2000's | 17 (19.10) | 29.6817 |
| 2010's | 19 (21.35) | 24.3611 |
| 2020's | 2 (2.25) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Li, Y; Zhang, Y | 1 |
| Jones, GL; Stickler, DJ | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Avdeef, A; Tam, KY | 1 |
| Akamatsu, M | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Yolton, DP | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Aragonés, E; Martí, R; Sarrà, N; Torres, M | 1 |
| Berry, SJ; Gotuzzo, E; Guzman, M; Leon-Barua, R; Maguiña, C; Oberhelman, RA; Ruiz, R; Sack, RB; Yi, A | 1 |
| Benonisen, E; Dibb, WL; Digranes, A | 1 |
| Boerema, JB | 1 |
| Bartlett, J; Champlin, RE; Deresinski, S; Finley, RS; Ho, WG; Joshi, JH; Karp, J; Levitt, L; Talbot, G; Winston, DJ | 1 |
| Aitken, JM; Bailey, RR; Ewer, TC; Gilchrist, NL; Sainsbury, R | 1 |
| Kawaguchi, K; Yamaguchi, K | 1 |
| Chan, MK; Cheng, IK; Li, MK; Wong, WS; Wong, WT; Yin, PD | 1 |
| Chongthaleong, A; Petcharabutr, OA; Sitprija, V; Tungsanga, K; Udomsantisuk, N; Wong, EC | 1 |
| Lolekha, S; Patanachareon, S; Thanangkul, B; Vibulbandhitkit, S | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H | 1 |
| Schaeffer, AJ; Sisney, GA | 1 |
| Hoagland, VL; Sabbaj, J; Shih, WJ | 1 |
| Alpert, ML; Ginsberg, BP; Goldstein, EJ | 1 |
| Fontana, R; Meloni, GA; Rossi, L | 1 |
| Dubini, F; Riviera, L | 2 |
| Corrado, ML; Hesney, M; Struble, WE | 1 |
| Bow, EJ; Louie, TJ; Rayner, E | 1 |
| Alpert, ML; Cherubin, CE; Eng, RH; Ginsburg, BP; Goldstein, EJ; Kahn, RM; Najem, A | 1 |
| Corrado, ML; Dupont, HL; Sabbaj, J | 1 |
| Boyko, EJ; Cox, CE; Goldstein, EJ; Kurtz, TO; Miller, K; Mummaw, N; Reller, LB; Stein, GE | 1 |
| Norrby, SR; Rylander, M; Svärd, R | 1 |
| Dubini, F; Riviera, L; Visconti, A | 1 |
| Cook, T; Hoagland, VL; Sabbaj, J | 1 |
| Dournon, E; Rajagopalan, P; Vildé, JL | 1 |
| Bille, J; Darioli, R; de Vevey, P; Glauser, MP | 1 |
| Albini, E; Belluco, G; Marca, G | 1 |
| Borsotto, M; Carlone, NA; Cuffini, AM; Savoia, D | 1 |
| Abruzzo, GK; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Pelak, BA | 1 |
| Drusano, GL; Morris, JG; Tenney, JH | 1 |
| Labthavikul, P; Neu, HC | 1 |
| Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
| Antunez de Mayolo, E; Benavente, L; Falconi, E; Guerra, JG; Palomino, JC | 1 |
| Daikos, GK; Giamarellou, H; Petrikkos, G; Tsagarakis, J | 1 |
| Chin, NX; Neu, HC | 1 |
| Barry, AL; Jones, RN | 1 |
| Currie, WJ; Deaney, NB; Round, EM; VandenBurg, MJ; Vogel, R | 1 |
| Newsom, SW | 1 |
| Bendall, MJ | 1 |
| Chait, I; Deaney, NB; Kelsey, MC; Newsom, RA; Newsom, SW; Round, EM; Smith, J; Toase, PD; Vogel, R; Watt, B | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Haase, DA; Harding, GK; Kennedy, JK; Ronald, AR; Thomson, MJ; Urias, BA | 1 |
| Abruzzo, GK; Fromtling, RA; Gadebusch, HH | 1 |
| Cocuzza, C; Cogo, R; Demartini, G; Raschi, S; Scaglione, F | 1 |
| Caparros-Wanderley, W; Ebringer, A; Senior, BW; Tiwana, H; Wilson, C | 1 |
| Cahen, P; Honderlick, P | 1 |
| Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J | 1 |
| Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
| Lobel, B | 1 |
| Amábile-Cuevas, CF; Arredondo-García, JL; Cardeñosa-Guerra, O; Corral, M; Costa, A; Figueroa-Damián, R; Hernández-Oliva, GM; Jáuregui, A; Merlos, RM; Olguín, J; Ríos-Fabra, A; Rosas, A | 1 |
| Kato, S; Le, TX; Munekage, Y | 1 |
| Burström, B; Ericsson, O; Ljung, R; Reimers, A | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Dang, Z; Huang, RP; Liu, ZH; Yin, H; Yuan, SF | 1 |
| Buetow, SA; Gauld, NJ; Ikram, RB; Thomas, MG; Zeng, IS | 1 |
| Gregory, WT; Guran, LA; McDonagh, MS; Price, JR | 1 |
| Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
| De Oliveira, T; Guégan, R; Le Gleuher, J; Sugahara, Y | 1 |
| Abebe, N; Ahmed, M; Awol, N; Bsrat, A; Gugsa, G; Hagos, Y; Tsegaye, Y | 1 |
7 review(s) available for trimethoprim and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
New antibacterial drugs for topical ophthalmic use.
Topics: Ciprofloxacin; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Norfloxacin; Ophthalmic Solutions; Polymyxin B; Trimethoprim | 1992 |
A review of urinary tract infection in the elderly.
Topics: Aged; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fosfomycin; Humans; Longitudinal Studies; Meta-Analysis as Topic; Nitrofurantoin; Norfloxacin; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2003 |
Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefaclor; Estriol; Female; Humans; Nitrofurantoin; Norfloxacin; Recurrence; Secondary Prevention; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
26 trial(s) available for trimethoprim and norfloxacin
| Article | Year |
|---|---|
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Topics: Adult; Clinical Trials as Topic; Diarrhea; Drug Combinations; Dysentery, Bacillary; Feces; Humans; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Humans; Middle Aged; Mycoses; Norfloxacin; Polymyxins; Random Allocation; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
Comparative study of norfloxacin and trimethoprim for the treatment of elderly patients with urinary tract infection.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Bacteriuria; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Random Allocation; Recurrence; Trimethoprim; Urinary Tract Infections | 1988 |
Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
Topics: Adult; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hong Kong; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1988 |
Norfloxacin versus co-trimoxazole for the treatment of upper urinary tract infections: a double blind trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1988 |
Norfloxacin versus co-trimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study.
Topics: Acute Disease; Adult; Bacterial Infections; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Humans; Male; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Topics: Adult; Drug Combinations; Female; Humans; Male; Norfloxacin; Paratyphoid Fever; Pefloxacin; Prospective Studies; Random Allocation; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1988 |
Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
Topics: Adult; Anal Canal; Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vagina | 1985 |
Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
Topics: Adult; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
Topics: Adult; Drug Combinations; Female; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestinal Diseases; Humans; Leukemia; Neutropenia; Norfloxacin; Skin Diseases; Sulfamethoxazole; Trimethoprim; Vancomycin | 1988 |
Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Female; Gram-Negative Bacteria; Humans; Leukemia; Male; Neutropenia; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Use of norfloxacin in the treatment of acute diarrheal disease.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Diarrhea; Drug Combinations; Feces; Humans; Microbial Sensitivity Tests; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Norfloxacin; Pyuria; Random Allocation; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1987 |
Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Norfloxacin; Prospective Studies; Random Allocation; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Prostatitis; Random Allocation; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1986 |
[Comparative study of the treatment of simple urinary infection with a single dose of norfloxacin versus cotrimoxazole].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Humans; Middle Aged; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1983 |
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Drug Administration Schedule; Drug Combinations; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Drug Combinations; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Feces; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urethra; Urinary Tract Infections | 1984 |
Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections.
Topics: Adult; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Norfloxacin; Trimethoprim; Urinary Tract Infections | 1995 |
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Latin America; Norfloxacin; Premenopause; Prospective Studies; Sulfamethoxazole; Time Factors; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2004 |
56 other study(ies) available for trimethoprim and norfloxacin
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Culture Media; Drug Tolerance; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Heat-Shock Response; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Transcription Factors | 2007 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim | 2009 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vitro susceptibility testing procedures for fosfomycin tromethamine.
Topics: Bacteria; Fosfomycin; Glucose-6-Phosphate; Glucosephosphates; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1991 |
[Single dose in therapeutic strategy in acute urinary tract infection].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Female; Humans; Norfloxacin; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1990 |
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Topics: 4-Quinolones; Acinetobacter; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cinoxacin; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Quinolones; Trimethoprim | 1985 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; Drug Administration Schedule; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Norfloxacin; Ofloxacin; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
Topics: Bacteria; Drug Combinations; Drug Resistance, Microbial; Fosfomycin; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Urine | 1988 |
Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
Topics: Administration, Oral; Adolescent; Adult; Bacteria; Cystitis; Drug Combinations; Fosfomycin; Humans; Male; Models, Biological; Norfloxacin; Pipemidic Acid; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1988 |
Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.
Topics: Administration, Oral; Animals; Bacterial Infections; Cystitis; Drug Combinations; Fosfomycin; Norfloxacin; Pipemidic Acid; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Experimental cystitis in the rat and the therapeutic effect of a single dose of fosfomycin trometamol].
Topics: Animals; Cystitis; Drug Combinations; Drug Evaluation, Preclinical; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Norfloxacin; Pipemidic Acid; Proteus Infections; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
Topics: Anti-Bacterial Agents; Doxycycline; Drug Combinations; Erythromycin; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Pefloxacin; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Topics: Culture Media; Drug Combinations; Escherichia coli; Fosfomycin; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urine | 1986 |
Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.
Topics: Bacterial Adhesion; Drug Combinations; Escherichia coli; Fosfomycin; Hemagglutination; Humans; Microbial Sensitivity Tests; Norfloxacin; Proteus mirabilis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1987 |
Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Infective Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Combinations; Escherichia coli Infections; Female; Mice; Mice, Inbred Strains; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1985 |
In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
Topics: Ampicillin; Chloramphenicol; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Tetracycline; Trimethoprim; Vibrio | 1985 |
In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Trimethoprim | 1982 |
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Digestive System; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Colony-Forming Units Assay; Drug Resistance, Microbial; Drug Synergism; Enoxacin; Microbial Sensitivity Tests; Mutagens; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Trimethoprim | 1983 |
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Topics: Acinetobacter; Anti-Infective Agents, Urinary; Bacteria; Cinoxacin; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pseudomonas; Pseudomonas aeruginosa; Quality Control; Reference Standards; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
The antimicrobial spectrum of norfloxacin.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Diabetes Mellitus, Experimental; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Gentamicins; Mice; Nalidixic Acid; Norfloxacin; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1984 |
Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Arthritis, Rheumatoid; Bacteriocins; Case-Control Studies; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Proteus Infections; Proteus mirabilis; Serotyping; Trimethoprim | 1998 |
[Nitrofurans: a modern treatment for uncomplicated urinary infections?].
Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurans; Nitrofurantoin; Norfloxacin; Trimethoprim; Urinary Tract Infections | 2000 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Hepatitis C; Humans; Kidney; Liver; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Sulfamethoxazole; Trimethoprim | 2002 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Antibiotic resistance in bacteria from shrimp farming in mangrove areas.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Aquaculture; Bacteria; Biodegradation, Environmental; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Environmental Monitoring; Geologic Sediments; Norfloxacin; Oxolinic Acid; Penaeidae; Sulfamethoxazole; Trimethoprim; Vietnam; Water Microbiology; Water Pollutants, Chemical | 2005 |
Inequality in quality? Regional and educational differences in treatment with fluoroquinolone in urinary tract infection of 236,376 Swedish patients.
Topics: Adolescent; Adult; Age Distribution; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Utilization; Female; Fluoroquinolones; Guideline Adherence; Healthcare Disparities; Humans; Middle Aged; Multivariate Analysis; Nitrofurantoin; Norfloxacin; Practice Patterns, Physicians'; Quality Indicators, Health Care; Risk Adjustment; Social Class; Sweden; Trimethoprim; Urinary Tract Infections | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Levels of six antibiotics used in China estimated by means of wastewater-based epidemiology.
Topics: Anti-Bacterial Agents; China; Cities; Erythromycin; Norfloxacin; Ofloxacin; Trimethoprim; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical | 2016 |
Treatment of uncomplicated cystitis: analysis of prescribing in New Zealand.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Cystitis; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Humans; Middle Aged; New Zealand; Nitrofurantoin; Norfloxacin; Pharmacies; Pregnancy; Pregnancy Complications; Surveys and Questionnaires; Trimethoprim; Young Adult | 2016 |
Tuning down the environmental interests of organoclays for emerging pollutants: Pharmaceuticals in presence of electrolytes.
Topics: Adsorption; Amoxicillin; Carbamazepine; Cations; Electrolytes; Environmental Restoration and Remediation; Hydrophobic and Hydrophilic Interactions; Metoprolol; Norfloxacin; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim; Water; Water Pollutants, Chemical; X-Ray Diffraction | 2020 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Chloramphenicol; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Goats; Meat; Microbial Sensitivity Tests; Norfloxacin; Prevalence; Streptomycin; Sulfamethoxazole; Trimethoprim | 2021 |